Christopher Kallus — 12 Patents at Sanofi

Christopher Kallus has been granted 12 US patents while listed as an inventor at Sanofi. The first was granted in 2004 and the most recent in December 2017. Christopher Kallus ranks #396,045 of 4,157,543 US inventors in our database (top 9.5%). Patent records list Christopher Kallus in Frankfurt am Main, DE.

Patents per Year

Issued Patents All Time

Showing 1–12 of 12 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
9834527	Macrocyclic urea derivatives as inhibitors of TAFIa, their preparation and their use as pharmaceuticals	Andreas Evers, Michael Wagner, Hermut Wehlan	2017-12-05	$11,040,000
9688645	Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa	Mark Broenstrup, Andreas Evers, Anja Globisch, Herman Schreuder, Michael Wagner	2017-06-27	$8,363,000
9309207	Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa	Mark Broenstrup, Andreas Evers, Anja Globisch, Herman Schreuder, Michael Wagner	2016-04-12	$28,790,000
9199947	Biaryl-propionic acid derivatives and their use as pharmaceuticals	Sven Ruf, Thorsten Sadowski, Klaus Wirth, Herman Schreuder, Christian Buning +2 more	2015-12-01	$29,379,000
9150526	Biaryl-propionic acid derivatives and their use as pharmaceuticals	Sven Ruf, Thorsten Sadowski, Klaus Wirth, Herman Schreuder, Christian Buning +2 more	2015-10-06	$13,840,000
9126955	Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa	Mark Broenstrup, Andreas Evers, Anja Globisch, Herman Schreuder, Michael Wagner	2015-09-08	$13,064,000
8722655	Macrocyclic urea and sulfamide derivatives as inhibitors of tafia	Mark Broenstrup, Andreas Evers, Anja Globisch, Herman Schreuder, Michael Wagner	2014-05-13	$14,619,000
8710232	Imidazole derivatives used as TAFIa inhibitors	Holger Heitsch, Andreas Lindenschmidt, Sven Grueneberg, Hauke Szillat	2014-04-29
8580777	Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa	Mark Broenstrup, Andreas Evers, Anja Globisch, Herman Schreuder, Michael Wagner	2013-11-12	$16,433,000
8389764	Urea and sulfamide derivatives as inhibitors of TAFIa	Mark Broenstrup, Werngard Czechtizky, Andreas Evers, Markus Follmann, Nis Halland +1 more	2013-03-05	$25,584,000
8044208	Imidazole derivatives as inhibitors of TAFIa	Holger Heitsch, Volkmar Wehner	2011-10-25	$7,633,000
6756489	Substituted tetrahydropyrane derivatives, method for producing same, their use as medicine or diagnostic agent, as well as medicine containing same	Wolfgang Schmidt, Stephan Henke, Horst Kunz, Till Opatz, Tobias Wunberg	2004-06-29	$5,971,000

Christopher Kallus — 12 Patents

Patents per Year

Issued Patents All Time

Patent Widget